BR112012031967A2 - composto, uso de um composto, combinação de um composto e composição farmacêutica - Google Patents
composto, uso de um composto, combinação de um composto e composição farmacêuticaInfo
- Publication number
- BR112012031967A2 BR112012031967A2 BR112012031967A BR112012031967A BR112012031967A2 BR 112012031967 A2 BR112012031967 A2 BR 112012031967A2 BR 112012031967 A BR112012031967 A BR 112012031967A BR 112012031967 A BR112012031967 A BR 112012031967A BR 112012031967 A2 BR112012031967 A2 BR 112012031967A2
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- combination
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10166894 | 2010-06-22 | ||
| PCT/EP2011/058802 WO2011160919A1 (en) | 2010-06-22 | 2011-05-30 | Alkaloid aminoester derivatives and medicinal composition thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112012031967A2 true BR112012031967A2 (pt) | 2019-09-24 |
Family
ID=43301943
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112012031967A BR112012031967A2 (pt) | 2010-06-22 | 2011-05-30 | composto, uso de um composto, combinação de um composto e composição farmacêutica |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8563577B2 (pt) |
| EP (1) | EP2585458B1 (pt) |
| KR (1) | KR20130087406A (pt) |
| CN (1) | CN102947299B (pt) |
| AR (1) | AR081966A1 (pt) |
| BR (1) | BR112012031967A2 (pt) |
| CA (1) | CA2803433A1 (pt) |
| HK (1) | HK1181768A1 (pt) |
| RU (1) | RU2567548C2 (pt) |
| WO (1) | WO2011160919A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2206712A1 (en) | 2008-12-23 | 2010-07-14 | CHIESI FARMACEUTICI S.p.A. | "Alkaloid aminoester derivatives and medicinal composition thereof" |
| RU2569846C2 (ru) * | 2010-06-22 | 2015-11-27 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Алкалоидные производные сложных аминоэфиров и включающие их лекарственные композиции |
| WO2012069275A1 (en) | 2010-11-26 | 2012-05-31 | Chiesi Farmaceutici S.P.A. | Glycine derivatives and their use as muscarinic receptor antagonists |
| RU2628082C2 (ru) | 2011-12-30 | 2017-08-14 | КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. | Хинуклидиновые эфиры 1-азагетероциклилуксусной кислоты в качестве антимускариновых средств, способ их получения и их лекарственные композиции |
| MX352351B (es) | 2012-07-02 | 2017-11-21 | Monsanto Technology Llc | Procesos para la preparacion de 1,2,4-oxadiazoles 3,5-disustituidos. |
| US9427376B2 (en) | 2013-10-10 | 2016-08-30 | Chiesi Farmaceutici S.P.A. | Process for preparing pharmaceutical formulations for inhalation comprising a high-dosage strength active ingredient |
| WO2016094690A1 (en) | 2014-12-10 | 2016-06-16 | Mars, Incorporated | Flavor compositions and pet food products containing the same |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1345937B1 (en) | 2000-12-22 | 2005-09-28 | Almirall Prodesfarma AG | Quinuclidine carbamate derivatives and their use as m3 antagonists |
| US6822073B2 (en) * | 2001-12-20 | 2004-11-23 | Kimberly-Clark Worldwide, Inc. | Modular peptide-based reagent |
| EA006505B1 (ru) | 2001-12-20 | 2005-12-29 | Лабораториос С.А.Л.В.А.Т.,С.А. | Производные карбамата 1-алкил-1-азониабицикло[2.2.2]октана и их применение в качестве антагонистов мускаринового рецептора |
| EP1882691A1 (en) | 2006-07-26 | 2008-01-30 | CHIESI FARMACEUTICI S.p.A. | Quinuclidine derivatives as M3 antagonists |
| ATE555111T1 (de) * | 2006-12-19 | 2012-05-15 | Astrazeneca Ab | Chinuclidinol-derivate als muscarinrezeptor- antagonisten |
| EP2154136A1 (en) | 2008-08-08 | 2010-02-17 | CHIESI FARMACEUTICI S.p.A. | Quinuclidine carbonate derivatives and medicinal compositions thereof |
| EP2206712A1 (en) | 2008-12-23 | 2010-07-14 | CHIESI FARMACEUTICI S.p.A. | "Alkaloid aminoester derivatives and medicinal composition thereof" |
-
2011
- 2011-05-30 EP EP11725021.7A patent/EP2585458B1/en active Active
- 2011-05-30 CN CN201180030598.3A patent/CN102947299B/zh not_active Expired - Fee Related
- 2011-05-30 BR BR112012031967A patent/BR112012031967A2/pt not_active IP Right Cessation
- 2011-05-30 CA CA2803433A patent/CA2803433A1/en not_active Abandoned
- 2011-05-30 RU RU2012155691/04A patent/RU2567548C2/ru active
- 2011-05-30 WO PCT/EP2011/058802 patent/WO2011160919A1/en active Application Filing
- 2011-05-30 KR KR1020127033568A patent/KR20130087406A/ko not_active Application Discontinuation
- 2011-06-21 AR ARP110102148A patent/AR081966A1/es unknown
- 2011-06-22 US US13/165,948 patent/US8563577B2/en active Active
-
2013
- 2013-08-06 HK HK13109177.1A patent/HK1181768A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CN102947299A (zh) | 2013-02-27 |
| US20110311459A1 (en) | 2011-12-22 |
| CN102947299B (zh) | 2015-07-15 |
| RU2012155691A (ru) | 2014-06-27 |
| AR081966A1 (es) | 2012-10-31 |
| WO2011160919A1 (en) | 2011-12-29 |
| US8563577B2 (en) | 2013-10-22 |
| KR20130087406A (ko) | 2013-08-06 |
| EP2585458B1 (en) | 2015-01-07 |
| HK1181768A1 (en) | 2013-11-15 |
| RU2567548C2 (ru) | 2015-11-10 |
| CA2803433A1 (en) | 2011-12-29 |
| EP2585458A1 (en) | 2013-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013008259A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR112013015397A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR112014001255A2 (pt) | composto, uso de um composto, combinação, e, composição farmacêutica | |
| BRPI1008793A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
| BRPI1016219A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR112014013760A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| BR112015000420A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BR112014029530A2 (pt) | compostos, composição farmacêutica e uso de um composto | |
| BR112014005669A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| BRPI1007018A2 (pt) | composto, composição farmacêutica, e , uso de um composto. | |
| BR112014029115A2 (pt) | composto, composição farmacêutica, e, uso de um composto ou composição | |
| BRPI0919942A2 (pt) | Composto, composição farmacêutica, e, uso de um composto | |
| BRPI0907562A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI0921375A2 (pt) | composto, composição farmacêutica, e, uso de um composto | |
| BRPI1008906A2 (pt) | composto, composição farmacêutica, e, uso de um composto. | |
| BR112014003567A2 (pt) | composto, uso de um composto, e, composição farmacêutica | |
| BR112013030302A2 (pt) | composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo | |
| BR112013011448A2 (pt) | composto, composição farnmacêutica, e, uso do composto | |
| BR112012031226A2 (pt) | composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica | |
| BRPI0921879A2 (pt) | composto, composição farmacêutica , e, uso de um composto | |
| BRPI0917579A2 (pt) | composto, composição farmacêutica, métodos, e, uso de um composto | |
| BR112014013177A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| BR112014013178A2 (pt) | composto, composição farmacêutica e uso de um composto | |
| BR112014009471A2 (pt) | compostos, combinação de um composto, composição farmacêutica, uso de um composto, dispositivo e kit | |
| BRPI0906937A2 (pt) | composto, composição farmacêutica, e, uso de um composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |